SafeHeal
PrivateLast Round
Series C
Extension
Sep 10, 2025
Total Funding Raised
$115.86M
Company Overview
SafeHeal operates in Healthcare & Life Sciences and is based in Paris. Its latest recorded funding round was a Series C Extension round in September 2025.
SafeHeal is a medical device company that develops Colovac, an endoluminal bypass sheath designed to protect colorectal anastomosis and eliminate the need for diverting ostomies in patients undergoing colorectal surgery.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SafeHeal Comparables
Compare SafeHeal with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Averto Medical | 89% | |
| Galmed Pharmaceuticals Ltd. | 88% | |
| SafeGuard Surgical | 84% |
For institutional investors. Book with your work email.
SafeHeal Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C Extension | Sep 10, 2025 | ||||
| Series C | Apr 29, 2025 | ||||
| Series B | Jan 31, 2022 | ||||
| Series A | Mar 27, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
SafeHeal Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Asabys Partners | Series C, Series C Extension |
| Gideon Strategic Partners | Series C, Series C Extension |
| Sofinnova Partners | Series C, Series C Extension, Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 7, 2026
Grew 20% QoQ from 25 to 30 employees.
- May 12, 2026
Monthly visitors increased 31% MoM.
For institutional investors. Book with your work email.
SafeHeal Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about SafeHeal's valuation, stock price, and market status.
Is SafeHeal a public or private company?
SafeHeal is a private company.
What is the current stock price of SafeHeal?
SafeHeal is a private company, so its shares have no public market price. Caplight tracks SafeHeal's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is SafeHeal worth (valuation)?
Valuation information for SafeHeal is not publicly available.
Can I buy SafeHeal stock?
SafeHeal shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was SafeHeal's last funding round?
SafeHeal's most recent funding round was Series C Extension on September 10, 2025.
Who are the main investors in SafeHeal?
Key investors in SafeHeal include Asabys Partners, Sofinnova Partners.
Will SafeHeal IPO soon?
No public IPO plans have been announced for SafeHeal.
How can I track SafeHeal secondary market activity?
Caplight tracks bids, offers, and trades in SafeHeal's shares on secondary markets.